- Home
- PSTV vs CVM Comparison
PSTV vs CVM Comparison
Compare PSTV & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- CVM
- Stock Information
- Founded
- PSTV 1996
- CVM 1983
- Country
- PSTV United States
- CVM United States
- Employees
- PSTV N/A
- CVM N/A
- Industry
- PSTV Medical/Dental Instruments
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PSTV Health Care
- CVM Health Care
- Exchange
- PSTV Nasdaq
- CVM Nasdaq
- Market Cap
- PSTV 17.0M
- CVM 19.6M
- IPO Year
- PSTV N/A
- CVM 1987
- Fundamental
- Price
- PSTV $0.37
- CVM $3.98
- Analyst Decision
- PSTV Strong Buy
- CVM
- Analyst Count
- PSTV 3
- CVM 0
- Target Price
- PSTV $10.83
- CVM N/A
- AVG Volume (30 Days)
- PSTV 65.2M
- CVM 1.7M
- Earning Date
- PSTV 08-13-2025
- CVM 08-14-2025
- Dividend Yield
- PSTV N/A
- CVM N/A
- EPS Growth
- PSTV N/A
- CVM N/A
- EPS
- PSTV N/A
- CVM N/A
- Revenue
- PSTV $5,206,000.00
- CVM N/A
- Revenue This Year
- PSTV $14.10
- CVM N/A
- Revenue Next Year
- PSTV $7.96
- CVM N/A
- P/E Ratio
- PSTV N/A
- CVM N/A
- Revenue Growth
- PSTV N/A
- CVM N/A
- 52 Week Low
- PSTV $0.16
- CVM $1.98
- 52 Week High
- PSTV $2.31
- CVM $66.60
- Technical
- Relative Strength Index (RSI)
- PSTV 52.77
- CVM 64.82
- Support Level
- PSTV $0.27
- CVM $3.30
- Resistance Level
- PSTV $0.38
- CVM $4.25
- Average True Range (ATR)
- PSTV 0.03
- CVM 0.61
- MACD
- PSTV 0.01
- CVM 0.26
- Stochastic Oscillator
- PSTV 81.82
- CVM 38.83
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.